Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa

Daniel Kiiza; Danial Rostami‐Hochaghan; Yussif Alhassan; Kay Seden; Helen Reynolds; Julian Kaboggoza; Miriam Taegtmeyer; Tao Chen; Elizabeth Challenger; Thokozile R. Malaba; Duolao Wang; Laura Else; Faye Y. Hern; Joanne Sharp; Megan Neary; Sujan Dilly Penchala; Catriona Waitt; Catherine Orrell; Angela Colbers; Landon Myer; Andrew Owen; Steve P. Rannard; Saye Khoo; Mohammed Lamorde

doi:10.1093/jac/dkae232

Abstract

We investigated the impact of Drug-Drug Interactions (DDIs) on virologic control among HIV-positive pregnant women initiating antiretroviral therapy while identifying drivers for Traditional Medicine (TM) use and exploring the nature and extent of TM-related DDIs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kiiza et al. (2024) studied this question.

synapsesocial.com/papers/68e6066db6db64358759a47a https://doi.org/10.1093/jac/dkae232

View at Publisher

Ask AI

Bookmark

Share

Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa

Abstract

Discussion

Cite This Study

Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Journal of Antimicrobial Chemotherapy

Keep reading

More related papers

More from Journal of Antimicrobial Chemotherapy